Loading company…
Stentit develops regenerative stents for cardiovascular treatment.
Founded in 2017 and based in Eindhoven, Netherlands, Stentit develops regenerative medical devices for cardiovascular conditions. Its technology supports endovascular treatment using regenerative stents. In April 2022, the company raised EUR 1.8 million in seed funding from NextGen Ventures, BOM Brabant Ventures, and Ten Cate Investeringsmaatschappij to support development and manufacturing for peripheral applications.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in